Pure Global
NCT02833168

Screening Questionnaire for Respiratory Muscle Weakness and Sleep-disordered Breathing in Neuromuscular Disorders

Validation of a German Language Screening Questionnaire for Symptoms of Respiratory Muscle Weakness and Sleep-disordered Breathing in Patients With Neuromuscular Disorders
Westfälische Wilhelms-Universität Münster·ClinicalTrials.gov·other
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Neuromuscular Disorders
Drug/Device/Intervention
patient-filled questionnaires
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Westfälische Wilhelms-Universität Münster
Location
Münster,Solingen, Germany
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2016
End date
Dec 01, 2016
Enrollment
90 participants
Primary outcome

Nocturnal hypercapnia tcCO2

Summary

It is the aim of this project to develop and validate a German language screening
 questionnaire for symptoms of respiratory muscle weakness and sleep-disordered breathing
 (SDB) in patients with neuromuscular disorders.

ICD-10 classifications
Other disorders of muscleDisorders of musclesOther specified disorders of musclePrimary disorders of musclesOther primary disorders of muscles
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT02833168
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT02833168 through Pure Global AI's free database. This phase not specified trial is sponsored by Westfälische Wilhelms-Universität Münster and is currently status unknown. The study focuses on Neuromuscular Disorders. Target enrollment is 90 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.